Hubei Jumpcan Pharmaceutical Co., Ltd. (SHA:600566)
China flag China · Delayed Price · Currency is CNY
26.72
+0.04 (0.15%)
Apr 28, 2026, 3:00 PM CST

SHA:600566 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
3,9295,4396,6697,7384,8193,819
Trading Asset Securities
8,6476,2665,1613,1783,0451,675
Cash & Short-Term Investments
12,57611,70511,83010,9167,8635,494
Cash Growth
-0.06%-1.06%8.37%38.82%43.13%30.28%
Accounts Receivable
1,1772,1092,2572,7822,8502,183
Other Receivables
29.0127.8112.514.9917.211.98
Receivables
1,2062,1372,2702,7972,8672,195
Inventory
369.63309.67569.09490.08391.48375.59
Other Current Assets
65.2328.6832.632.554.2358.34
Total Current Assets
14,21714,18014,70214,23511,1778,123
Property, Plant & Equipment
2,3762,4452,7062,9222,8563,034
Long-Term Investments
493.89473.11464.71393.97332.34328.44
Goodwill
167.3167.3167.3167.3167.3167.3
Other Intangible Assets
387.88337.89308.56305.01320.62280.04
Long-Term Deferred Tax Assets
35.0249.4441.8345.4562.1657.32
Long-Term Deferred Charges
9.0910.012.3811.913.8713.19
Other Long-Term Assets
151.2837.7966.4462.1662.14127.96
Total Assets
17,83717,70018,45918,14414,98112,131
Accounts Payable
1,0341,3141,7302,1411,505945.77
Accrued Expenses
68.88125.55254.87246.62350.39242.7
Short-Term Debt
748.93696836.391,088400-
Current Portion of Long-Term Debt
68.5768.67---627.55
Current Portion of Leases
--1.071.060.441.55
Current Income Taxes Payable
111.86280.8799.77182.62106.0943.71
Current Unearned Revenue
17.6313.6217.9217.2549.1419.34
Other Current Liabilities
554.78377.17598.01915.861,016919.98
Total Current Liabilities
2,6052,8763,5384,5923,4272,801
Long-Term Debt
20.5-----
Long-Term Leases
0.540.811.041.430.21.02
Long-Term Unearned Revenue
55.9258.1465.4571.4378.1984.63
Long-Term Deferred Tax Liabilities
140.2132.6127.84109.28122.05112.38
Other Long-Term Liabilities
0.260.290.530.821.061.35
Total Liabilities
2,8223,0683,7334,7753,6293,000
Common Stock
452.66452.51452.69452.74452.74436.27
Additional Paid-In Capital
4,0244,0164,0123,9993,9843,148
Retained Earnings
10,60410,20410,3459,0106,9985,431
Treasury Stock
-91.74-66.74-108.57-111.97-97.18-
Comprehensive Income & Other
-----100.81
Total Common Equity
14,98914,60614,70213,34911,3379,117
Minority Interest
26.0327.1124.5719.4215.1414.17
Shareholders' Equity
15,01514,63314,72613,36911,3529,131
Total Liabilities & Equity
17,83717,70018,45918,14414,98112,131
Total Debt
838.53765.49838.51,090400.65630.12
Net Cash (Debt)
11,73710,93910,9929,8267,4634,864
Net Cash Growth
-1.28%-0.48%11.86%31.67%53.43%34.56%
Net Cash Per Share
12.7711.8811.9810.728.225.40
Filing Date Shares Outstanding
909.41921.25912.53921.81921.82888.27
Total Common Shares Outstanding
909.41921.25912.53921.81921.82888.27
Working Capital
11,61211,30411,1649,6447,7495,322
Book Value Per Share
16.4815.8516.1114.4812.3010.26
Tangible Book Value
14,43414,10014,22612,87710,8498,670
Tangible Book Value Per Share
15.8715.3115.5913.9711.779.76
Buildings
--2,9532,9112,4552,473
Machinery
--1,7281,6851,6441,566
Construction In Progress
--156.63186.98352.15322.17
Updated Mar 31, 2026. Source: S&P Global Market Intelligence. Standard template. Financial Sources.